Concepedia

Catherine D. Pilsmaker

CD

Statistics

Publications

3

Citations

174

H-Index

3

Active since

2012

Affiliations

Celldex Therapeutics (United States)(Current)

Catherine D. Pilsmaker is an author at Celldex Therapeutics (United States) specializing in oncology, cancer immunotherapy, and life sciences.

Publications per year

2012–2016

3

Publications

3

Agonist Anti-Human CD27 Monoclonal Antibody Induces T Cell Activation and Tumor Immunity in Human CD27–Transgenic Mice

Li-Zhen He, Naseem Prostak, Lawrence J. Thomas et al. · The Journal of Immunology · 2013 · 102 citations

, , +17

Development of a Novel Antibody–Drug Conjugate for the Potential Treatment of Ovarian, Lung, and Renal Cell Carcinoma Expressing TIM-1

Lawrence J. Thomas, Laura Vitale, Thomas J. O’Neill et al. · Molecular Cancer Therapeutics · 2016 · 45 citations

, , +13

Robust changes in expression of brain-derived neurotrophic factor (BDNF) mRNA and protein across the brain do not translate to detectable changes in BDNF levels in CSF or plasma

Thomas A. Lanz, Susan E. Bove, Catherine D. Pilsmaker et al. · Biomarkers · 2012 · 27 citations

, , +16

1–3 of 3